FINWIRES · TerminalLIVE
FINWIRES

Roku Poised to Exceed 2026 Outlook for Revenue Growth, Wedbush Says

By

-- Roku (ROKU) is poised to exceed its 2026 guidance for high-teens revenue growth, increasing earnings before interest, taxes, depreciation and amortization margin, and rising free cash flow, leading to $1 billion in FCF by 2028, Wedbush said in a note Monday

Roku's accelerating monetization with an underappreciated runway, improving profitability, and a favorable tax position places it on Wedbush's best ideas list, the brokerage added.

Roku is scheduled to release its Q1 financial results after the stock market closes on Thursday.

Wedbush said it expects Roku's Q1 revenue to be $1.205 billion, compared with consensus of $1.204 billion and guidance of $1.2 billion. The brokerage modeled Platform revenue growth of 22% year-over-year to about $1.08 billion, ad revenue to grow 19% to $577 million, subscription revenue to rise 25% to $499 million, and Devices revenue to decline 7% to $130 million.

2026 revenue guidance of $5.5 billion and adjusted EBITDA of $635 million has upside potential from a strong political cycle this year, the brokerage said.

Wedbush believes Roku is best positioned among streamers, even as ad budgets get tighter amid global conflicts and rising gas prices, as it can meet advertisers across the demand curve.

Wedbush maintained an outperform rating on Roku with a price target of $140.

Price: $113.37, Change: $-1.86, Percent Change: -1.61%

Related Articles

Australia

Alignment Healthcare Swings to Q1 Profit, Revenue Rises; Shares Fall After Hours

Alignment Healthcare (ALHC) reported Q1 earnings late Thursday of $0.05 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.01.Revenue in the three months ended March 31 rose to $1.24 billion from $926.9 million a year ago.Analysts surveyed by FactSet expected $1.22 billion.The company expects revenue of $1.3 billion to $1.32 billion in Q2 and $5.16 billion to $5.21 billion in the full year.Analysts project $1.31 billion in Q2 and $5.17 billion in 2026.Alignment Healthcare shares fell 10% in after-hours trading.

$ALHC
Research

Research Alert: Columbia Sportswear Company Beats Estimates; Raises Full-year Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:COLM posted Q1 2026 EPS of $0.65 vs. $0.75 prior year, $0.30 above consensus on flat net sales of $779M, $21M above estimates. International diversification proved valuable with EMEA surging 35% and LAAP growing 5%, offsetting a 10% U.S. decline, while gross margin contracted 20 bps to 50.7% primarily from a 310-bp incremental tariff impact. We believe the international growth strategy is effectively insulating the company from U.S. tariff headwinds and positioning it for sustained global expansion. Management raised full-year EPS guidance to $3.55-$4.00 from prior $3.20-$3.65 and operating margin guidance to 6.7%-7.5% reflecting better tariff conditions. The company maintains its fortress balance sheet with $535.4M cash and no debt while executing a $150M share repurchase program. We are impressed with international performance driving growth and expect continued momentum from the ACCELERATE Growth Strategy targeting younger consumers, with shares trading at 17x forward EPS guidance.

$COLM
Mining & Metals

Fairfax India Holdings Corp Announcing FY25 Net Earnings of US$410.5M or $3.05 Net Earnings Per Diluted Share

$FIH-U.TO